Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
Biology of Bladder Cancer (R21 Clinical Trial Optional)
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications investigating the biology and underlying mechanisms of bladder cancer.
Bladder cancer is a significant health problem both in the United States and globally.
Because of the high incidence and frequent tumor recurrence, bladder cancer exacts an outsized medical burden.
While recent progress has been made in the molecular profiling of bladder cancers and identification of mutated genes, relatively little is known regarding the molecular mechanisms driving initiation, progression, and malignancy of bladder cancer.
Furthermore, our understanding of biological processes of the normal bladder at the molecular, cell and organ levels is limited.
Fundamental knowledge of how molecular and cellular functions of the bladder are altered in cancer will aid our understanding of bladder cancer biology and interventions.
Applications that involve multidisciplinary teams and use clinical specimens or investigate both normal and cancer processes are encouraged.
Bladder cancer is a significant health problem both in the United States and globally.
Because of the high incidence and frequent tumor recurrence, bladder cancer exacts an outsized medical burden.
While recent progress has been made in the molecular profiling of bladder cancers and identification of mutated genes, relatively little is known regarding the molecular mechanisms driving initiation, progression, and malignancy of bladder cancer.
Furthermore, our understanding of biological processes of the normal bladder at the molecular, cell and organ levels is limited.
Fundamental knowledge of how molecular and cellular functions of the bladder are altered in cancer will aid our understanding of bladder cancer biology and interventions.
Applications that involve multidisciplinary teams and use clinical specimens or investigate both normal and cancer processes are encouraged.
Agency: Department of Health and Human Services
Office: National Institutes of Health
Estimated Funding: $200,000
Office: National Institutes of Health
Estimated Funding: $200,000
Who's Eligible
Relevant Nonprofit Program Categories
Obtain Full Opportunity Text:
https://grants.nih.gov/grants/guide/pa-files/PAR-25-128.html
Additional Information of Eligibility:
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U. S. Territory or Possession.
Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/pa-files/PAR-25-128.html
Contact:
Agency Email Description:
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Agency Email:
Date Posted:
2024-11-19
Application Due Date:
Archive Date:
2025-10-13
